Global Life Sciences Trends and Opportunities 2012-2015
Global Life Sciences Trends and Opportunities 2012-2015
Pharma, Diagnostics, and Research Industry Converge to Address Complex Disease Challenge
13-Dec-2012
Global
Market Research
$4,950.00
Special Price $3,712.50 save 25 %
Frost & Sullivan’s global life sciences team analyzes the impact of important changes and key trends across the total pharmaceutical/biotechnology, diagnostics, and life sciences research industries. This research deliverable captures the global life sciences trends and opportunities for the period of 2012-2015, as supported by Frost & Sullivan’s proprietary research and leading industry experts. Our global life sciences team is uniquely positioned to provide comprehensive analysis and guidance in the converging landscape. Topics include generics and biosimilars, emerging markets, pharmaceutical outsourcing, novel therapeutics, next generation diagnostics, research and development laboratories, and clinical laboratories.
Introduction
- Title, Research Team and Contents
Executive Summary
- Executive Summary
Daunting Challenges for the Pharmaceutical Industry
- Daunting Challenges
Pharma’s New Growth Strategies
- Strategies
Curbing the Costs of Drug Development
- Development
Lean Laboratories—Doing More With Less
- Lean Laboratories
Novel Biomarker Discovery Leading to Novel Therapeutics
- Novel Therapeutics
Genetic Technologies are Integral to Healthcare
- Genetic Technologies are Integral
Conclusions
- The Last Word
Appendix
- Additional Information
The Frost & Sullivan Story
- About Frost & Sullivan
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Deliverable Type | Market Research |
---|---|
No Index | Yes |
Podcast | No |
Author | Winny Tan |
Industries | Healthcare |
WIP Number | NB98-01-00-00-00 |
Is Prebook | No |